1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBiobusiness Grants is sponsored by Regenerative Medicine Minnesota. These grants aim to develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services.
Get alerted about grants like this
Save a search for “Regenerative Medicine Minnesota” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Biobusiness Development Grants Awarded | Regenerative Medicine Minnesota Biobusiness Development Grants Awarded Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions .
age-related macular degeneration cell isolation and selection equipment chronic obstructive pulmonary disorder gene modified cell therapy Innovation and Business Incubator Facility masters stem cell biology Muscular Dystrophy stem cell research Neurodegenerative disease neurodegenerative disorder Regenerative Medicine Minnesota undergraduate internships View bio business grants awarded by year.
Richard Murphy, General Manager Development of regenerative engineered tissue embedded cardiovascular device The aim of this grant proposal is to develop cardiovascular devices at Vascudyne with regenerative engineered tissue technology licensed from the… Human hematopoiesis in genetically modified swine Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity… Automation of cell culture with a Terumo Quantum Cell Expansion System to create recellularized bioengineered whole organs Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular… Therapeutic & IP optimization of provisionally-patented anti-inflammatory wound healing-accelerant This project is performing translational studies on a wound-healing accelerant that has been provisionally patented.
Animal studies showed that… Vanesa Alonso-Camino, PhD Development of technolgy for the large-scale production of a novel dendritic cell vaccine for the treatment of glioblastoma We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor… Timothy D.
O'Brien, DVM, PhD Development of a Cellular Therapy for Parkinson's Disease Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.
In the present proposal we will evaluate… Development of a Perfusion-Based Testing System to Evaluate Short-Term Function in Bioengineered Kidney Grafts Miromatrix is working to create a new source of kidney grafts for thousands of patients suffering from kidney failure who are wait-listed for… Increased Application of Novel Regenerative Therapeutics Achieved Through Integrated CGMP Process Development Optimization The Mayo Clinic CRM Biotrust has the role of escalating promising cellular and acellular biologics from bench to clinical-grade products, through… Building a Stem Cell Innovation and Business Incubator Facility at the UMN Stem Cell Institute Funding to equip laboratory space at the UMN Stem Cell Institute to provide a shared-space Innovation and Prototype Facility to support start-up… Miltenyi CliniMACS Equipment Grant Equipment for CD34 cell isolation and selection in our planned cGMP operation for regenerative medicine.
Multi-Modal Imaging Platform for Monitoring Regenerative Therapy This proposal aims to establish the state‐of‐the‐art ultrasound platform armed with photoacoustic technology specialized for regenerative therapies… Molecular Farming of BMPs and Fibronectin The goal of this project is to prove that commercial production of regenerative proteins can be made consistently and with a significant cost…
According to the current listing, eligibility includes: Minnesota-based businesses involved in regenerative medicine, including startups and those developing neural tissues or cell therapies. Confirm the full requirements in the official notice before applying.
Biobusiness Grants is funded by Regenerative Medicine Minnesota. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Minnesota. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
EPA's Gulf of America Farmer-to-Farmer program awards $1.5M-$2.5M grants for farmer-led organizations scaling regenerative agriculture. Applications due June 19, 2026.
Read articleThe $46M FSHARP program is creating shelf-stable synthetic blood from freeze-dried components. A new SWiFT SBIR topic opened May 6 for autonomous field transfusion devices. What grant seekers in biomedical engineering need to know.
Read articleThe administration is investing $1 billion in regenerative agriculture while proposing $4.9 billion in USDA cuts. Farmers and ag researchers face a funding landscape where priorities are shifting faster than programs can adapt.
Read article